Statistics

Total Visits

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial25

File Visits

Downloads
7415-31389.pdf22

Select a period of time:

Number of views in the range

Views
Response-adapted treatment with rituximab, bendamustine, mitoxantrone, and dexamethasone followed by rituximab maintenance in patients with relapsed or refractory follicular lymphoma after first-line immunochemotherapy: Results of the RBMDGELTAMO08 phase II trial10

Number of downloads in the range

Downloads
7415-31389.pdf4

Views

Views
September 20240
October 20240
November 20240
December 20240
January 20252
February 20250
March 20258
Download CSV file
 untranslated
 untranslated

Number of downloads in the period of time

  • Downloads
  • September 2024
    0
  • October 2024
    0
  • November 2024
    0
  • December 2024
    0
  • January 2025
    4
  • February 2025
    0
  • March 2025
    0
  • Download CSV file
 untranslated
 untranslated

Top country views

Views
Singapore10
 

Top countries by downloads

Downloads
Singapore1
 

Top cities views

Views